The report covers the company's activities from April 1, 2018 to March 31, 2019. ONO PHARMACEUTICAL launched three new drugs on the market in FY2018 and applied for approval for new drugs and supplemental approval for many additional indications. In FY2019, the company plans to launch three new drugs and file many approval applications. The company also transferred the domestic marketing approval for 11 long-listed products to Maruishi Pharmaceutical in order to focus on discovering new drugs.
Issuing Company Ono Pharmaceutical Co., Ltd.
Report Type Integrated Report
Report Language EN
Report Filesize 6.76 MB
No. of Pages 126 pages
Reporting periodApril 1, 2018-March 31, 2019
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; ISO 26000; UNSDG
Materiality Assessmenttrue